Category Archives: – Biotech

The State of New York is still mandating the deadly COVID shots to kids and pregnant women

September 10, 2026- by Steven E. Greer

Posted in - Biotech, - Opinion, - Pharma, CDC, DARPA and Military, FDA, Geriatrics, Infectious disease, Internal Medicine, Obstetrics and Gynecology, Pediatrics | Leave a comment

Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market

The transcript is found here May 19, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, CDC, Congress, FDA, Genetics, Infectious disease, NIH, Oncology | 9 Comments

New paper explains the mysterious rubbery clots inside of vessels after COVID shots

Title:

Posted in - Biotech, - Medical Devices, - Opinion, - Policy, DARPA and Military, Genetics | 1 Comment

Steven E. Greer, MD on OANN discussing virus therapies

April 16, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, CDC, CMS, Congress, Emergency medicine, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Pediatrics, Primary care medicine, Pulmonology, VA | Leave a comment

Exclusive: The FDA investigates Don Huffines: The new owner of Epstein’s New Mexico ranch

February 18, 2026- by Steven Greer, MD

Posted in - Biotech, FDA | Leave a comment

CRISPR is the biggest threat to mankind

June 23, 2021- by Steven E. Greer Today, I received my media embargo copy of a New England Journal of Medicine article on genetic engineering

Posted in - Biotech, - Opinion, - Policy, Congress, FDA, Genetics, NIH | Leave a comment

FDA to limit COVID shot approval to elderly, those with medical conditions

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

Posted in - Biotech, - Pharma, CDC, FDA, Geriatrics, Infectious disease, Internal Medicine | Leave a comment

Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies

July 12, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology | Leave a comment

Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)

Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.

Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease | Leave a comment

The U.S. Military’s Moderna Division Rams Through Another Untested mRNA Gene Therapy

June 1, 2024- by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, CDC, Congress, FDA, Infectious disease, NIH | Leave a comment

Florida becomes the first state to recommend against getting the gene therapy “vaccines” for COVID

October 9, 2022- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Harvard, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine | Leave a comment

mRNA vaccine boosters and impaired immune system response

February 3, 2024- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, CDC, Congress, FDA, Infectious disease | Leave a comment

Any type of coronavirus vaccine (i.e., gene therapy) that uses the spike-protein will be deadly

February 20, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, FDA | Leave a comment

Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham

July 7, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH | Leave a comment

Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity

September 1, 2023- by Sucharit Bhakdi, MD et al

Posted in - Biotech, - Pharma, - Reviews, books, devices, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology, Pediatrics | Leave a comment

Ivermectin works against COVID in double blind, randomized, controlled trial

May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.

Posted in - Biotech, - Generics, - Pharma, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine | Leave a comment

Did the COVID vaccines change the human genome?

May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology | Leave a comment

Joe Piscopo interviews Steven E. Greer, MD: 5-22-2020

May 22, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Pulmonology | Leave a comment

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer,

Posted in - Biotech, - Generics, FDA | Leave a comment